Gene One Life Science Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Gene One Life Science Inc

Watchlist Manager

Watchlist

Price: 2 670 KRW Market Closed

Market Cap: ₩48.5B

	Gene One Life Science Inc KRX:011000	KR
A	Autodesk Inc XMUN:AUD	US
	Central Depository Services (India) Ltd NSE:CDSL	IN
T	Telefonica SA XMUN:TNE2	ES
U	U-Neuron Biomedical Inc TPEX:6973	TW
I	Imperial Brands PLC OTC:IMBBF	UK
	Uflex Ltd NSE:UFLEX	IN
	BNK Banking Corporation Ltd ASX:BBC	AU
M	Millennium Global Holdings Inc XPHS:MG	PH
L	Lepanto Consolidated Mining Co XPHS:LCB	PH

Profitability Summary

Gene One Life Science Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-136%

Negative 3Y Average Gross Margin

-45%

Declining Gross Margin

-25% > -136%

Negative Operating Margin

-323%

Negative 3Y Average Operating Margin

-175%

Declining Operating Margin

-144% > -323%

Negative Net Margin

-396%

Negative 3Y Average Net Margin

-201%

Declining Net Margin

-141% > -396%

Negative Free Cash Flow Margin

-108%

Negative 3Y Average Free Cash Flow Margin

-65%

Declining Free Cash Flow Margin

-102% > -108%

Negative ROE

-100%

Negative 3Y Average ROE

Negative 3Y Average ROIC